0 XP   0   0   0

IMCD NV










Financial Health of IMCD NV




Comparing to competitors in the Specialty Chemicals industry




  Industry Rankings  


Richest
#98 / 578

Total Sales
#567 / 578

Making Money
#75 / 578

Working Efficiently
#466 / 578

IMCD NV
Buy, Hold or Sell?

Should you buy, hold or sell IMCD NV?

I guess you are interested in IMCD NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse IMCD NV

Let's start. I'm going to help you getting a better view of IMCD NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is IMCD NV even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how IMCD NV is doing in the market. If the company is worth buying. The latest step is to find out how other investors value IMCD NV. The closing price on 2022-12-01 was €142.85 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
IMCD NV Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of IMCD NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit IMCD NV earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare IMCD NV to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IMCD NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y2.6%-0.4%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-7.2%
TTM-6.1%-6.1%
YOY-7.0%-7.0%
5Y2.2%6.2%-4.0%
10Y2.6%6.2%-3.6%
1.1.2. Return on Assets

Shows how efficient IMCD NV is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IMCD NV to the Specialty Chemicals industry mean.
  • 2.3% Return on Assets means that IMCD NV generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IMCD NV:

  • The MRQ is 2.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.1%+0.3%
TTM2.1%YOY1.5%+0.6%
TTM2.1%5Y1.7%+0.4%
5Y1.7%10Y1.3%+0.4%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%1.6%+0.7%
TTM2.1%1.5%+0.6%
YOY1.5%1.6%-0.1%
5Y1.7%1.4%+0.3%
10Y1.3%1.4%-0.1%
1.1.3. Return on Equity

Shows how efficient IMCD NV is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IMCD NV to the Specialty Chemicals industry mean.
  • 5.5% Return on Equity means IMCD NV generated €0.06 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IMCD NV:

  • The MRQ is 5.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.5%TTM4.7%+0.8%
TTM4.7%YOY3.4%+1.3%
TTM4.7%5Y4.1%+0.7%
5Y4.1%10Y3.1%+1.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5%3.0%+2.5%
TTM4.7%2.8%+1.9%
YOY3.4%2.9%+0.5%
5Y4.1%2.6%+1.5%
10Y3.1%2.7%+0.4%

1.2. Operating Efficiency of IMCD NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient IMCD NV is operating .

  • Measures how much profit IMCD NV makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IMCD NV to the Specialty Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IMCD NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.0%-3.0%
5Y3.0%10Y2.4%+0.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.5%-8.5%
TTM-7.8%-7.8%
YOY-9.2%-9.2%
5Y3.0%7.8%-4.8%
10Y2.4%6.3%-3.9%
1.2.2. Operating Ratio

Measures how efficient IMCD NV is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of IMCD NV:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.850-0.850
5Y0.85010Y0.922-0.072
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.607-1.607
TTM-1.549-1.549
YOY-1.431-1.431
5Y0.8501.369-0.519
10Y0.9221.142-0.220

1.3. Liquidity of IMCD NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if IMCD NV is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 1.68 means the company has €1.68 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of IMCD NV:

  • The MRQ is 1.679. The company is able to pay all its short-term debts. +1
  • The TTM is 1.512. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.679TTM1.512+0.167
TTM1.512YOY1.321+0.191
TTM1.5125Y1.456+0.056
5Y1.45610Y1.003+0.453
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6791.794-0.115
TTM1.5121.730-0.218
YOY1.3211.743-0.422
5Y1.4561.672-0.216
10Y1.0031.487-0.484
1.3.2. Quick Ratio

Measures if IMCD NV is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IMCD NV to the Specialty Chemicals industry mean.
  • A Quick Ratio of 0.85 means the company can pay off €0.85 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IMCD NV:

  • The MRQ is 0.853. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.732. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.853TTM0.732+0.121
TTM0.732YOY0.645+0.087
TTM0.7325Y0.737-0.005
5Y0.73710Y0.801-0.064
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8530.839+0.014
TTM0.7320.834-0.102
YOY0.6450.864-0.219
5Y0.7370.811-0.074
10Y0.8010.803-0.002

1.4. Solvency of IMCD NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of IMCD NV assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IMCD NV to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.57 means that IMCD NV assets are financed with 57.3% credit (debt) and the remaining percentage (100% - 57.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IMCD NV:

  • The MRQ is 0.573. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.557. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.573TTM0.557+0.016
TTM0.557YOY0.559-0.002
TTM0.5575Y0.578-0.021
5Y0.57810Y0.618-0.040
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5730.442+0.131
TTM0.5570.425+0.132
YOY0.5590.434+0.125
5Y0.5780.429+0.149
10Y0.6180.430+0.188
1.4.2. Debt to Equity Ratio

Measures if IMCD NV is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IMCD NV to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 134.4% means that company has €1.34 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IMCD NV:

  • The MRQ is 1.344. The company is able to pay all its debts with equity. +1
  • The TTM is 1.260. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.344TTM1.260+0.083
TTM1.260YOY1.279-0.019
TTM1.2605Y1.382-0.122
5Y1.38210Y1.156+0.227
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3440.799+0.545
TTM1.2600.757+0.503
YOY1.2790.775+0.504
5Y1.3820.789+0.593
10Y1.1560.810+0.346

2. Market Valuation of IMCD NV

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings IMCD NV generates.

  • Above 15 is considered overpriced but always compare IMCD NV to the Specialty Chemicals industry mean.
  • A PE ratio of 84.23 means the investor is paying €84.23 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IMCD NV:

  • The EOD is 91.888. Neutral. Compare to industry.
  • The MRQ is 84.233. Neutral. Compare to industry.
  • The TTM is 146.573. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD91.888MRQ84.233+7.655
MRQ84.233TTM146.573-62.340
TTM146.573YOY171.395-24.822
TTM146.5735Y149.041-2.468
5Y149.04110Y123.777+25.264
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD91.88847.495+44.393
MRQ84.23349.507+34.726
TTM146.57362.325+84.248
YOY171.39562.396+108.999
5Y149.04161.867+87.174
10Y123.77751.163+72.614

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of IMCD NV is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 4.63 means the investor is paying €4.63 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of IMCD NV:

  • The EOD is 5.053. Seems overpriced? -1
  • The MRQ is 4.632. Neutral. Compare to industry.
  • The TTM is 6.338. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD5.053MRQ4.632+0.421
MRQ4.632TTM6.338-1.705
TTM6.338YOY5.664+0.673
TTM6.3385Y5.158+1.179
5Y5.15810Y3.323+1.836
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD5.0531.959+3.094
MRQ4.6322.102+2.530
TTM6.3382.387+3.951
YOY5.6642.116+3.548
5Y5.1581.934+3.224
10Y3.3231.586+1.737
2. Total Gains per Share

2.4. Latest News of IMCD NV

Does IMCD NV still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from IMCD NV to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-12-01
08:27
With 61% institutional ownership, IMCD N.V. (AMS:IMCD) is a favorite amongst the big gunsRead
2022-11-17
06:47
A Look At The Intrinsic Value Of IMCD N.V. (AMS:IMCD)Read
2022-11-10
07:00
IMCD reports 59% EBITA growth in the first nine months of 2022Read
2022-11-02
13:48
Declining Stock and Solid Fundamentals: Is The Market Wrong About IMCD N.V. (AMS:IMCD)?Read

3. Summary

3.1. Key Performance Indicators

The key performance indicators of IMCD NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.6061.234+111%2.113+23%0.787+231%0.785+232%
Book Value Growth--0.045-0.004+110%0.047-6%-0.014+132%0.021+108%
Book Value Per Share--28.26925.732+10%20.600+37%17.683+60%13.539+109%
Book Value Per Share Growth--0.0920.046+102%0.095-3%0.036+153%0.062+49%
Current Ratio--1.6791.512+11%1.321+27%1.456+15%1.003+67%
Debt To Asset Ratio--0.5730.557+3%0.559+3%0.578-1%0.618-7%
Debt To Equity Ratio--1.3441.260+7%1.279+5%1.382-3%1.156+16%
Dividend Per Share--0.8100.405+100%0.463+75%0.424+91%0.313+159%
Dividend Per Share Growth----315.1630%0.046-100%-66.3310%-43.3880%
Eps--1.5551.225+27%0.712+118%0.685+127%0.478+225%
Eps Growth---0.098-100%0.083-100%-0.0080%0.044-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.917+9%
Net Profit Margin----0%-0%0.022-100%0.026-100%
Operating Margin----0%-0%0.030-100%0.024-100%
Operating Ratio----0%-0%0.850-100%0.922-100%
Pb Ratio5.053+8%4.6326.338-27%5.664-18%5.158-10%3.323+39%
Pe Ratio91.888+8%84.233146.573-43%171.395-51%149.041-43%123.777-32%
Price Per Share142.850+8%130.950161.538-19%114.613+14%94.096+39%64.606+103%
Price To Total Gains Ratio41.822+8%38.338102338.687-100%141.764-73%20612.085-100%12898.108-100%
Profit Growth---5.2505.027-204%-26.207+399%-10.378+98%-0.176-97%
Quick Ratio--0.8530.732+16%0.645+32%0.737+16%0.801+7%
Return On Assets--0.0230.021+13%0.015+55%0.017+38%0.013+76%
Return On Equity--0.0550.047+17%0.034+60%0.041+36%0.031+78%
Total Gains Per Share--3.4161.639+108%2.576+33%1.211+182%1.098+211%
Total Gains Per Share Growth--0.763-1082.018+141928%-2.871+476%-217.343+28589%-132.162+17423%
Usd Book Value--1694250297.5001542129051.875+10%1234378578.125+37%1059636055.250+60%811300446.111+109%
Usd Book Value Change Per Share--2.7431.299+111%2.224+23%0.828+231%0.826+232%
Usd Book Value Per Share--29.75327.083+10%21.682+37%18.612+60%14.250+109%
Usd Dividend Per Share--0.8520.426+100%0.487+75%0.446+91%0.330+159%
Usd Eps--1.6361.289+27%0.750+118%0.721+127%0.503+225%
Usd Price Per Share150.350+8%137.825170.018-19%120.630+14%99.036+39%67.998+103%
Usd Profit--93173088.75073402928.750+27%42670718.125+118%43882935.000+112%30220929.514+208%
Usd Revenue----0%-0%463917292.563-100%438610415.382-100%
Usd Total Gains Per Share--3.5951.725+108%2.711+33%1.274+182%1.156+211%
 EOD+2 -3MRQTTM+22 -6YOY+21 -85Y+26 -510Y+24 -9

3.2. Fundamental Score

Let's check the fundamental score of IMCD NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1591.888
Price to Book Ratio (EOD)Between0-15.053
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.853
Current Ratio (MRQ)Greater than11.679
Debt to Asset Ratio (MRQ)Less than10.573
Debt to Equity Ratio (MRQ)Less than11.344
Return on Equity (MRQ)Greater than0.150.055
Return on Assets (MRQ)Greater than0.050.023
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of IMCD NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose142.050
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets3,770,290
Total Liabilities2,160,551
Total Stockholder Equity1,608,118
 As reported
Total Liabilities 2,160,551
Total Stockholder Equity+ 1,608,118
Total Assets = 3,770,290

Assets

Total Assets3,770,290
Total Current Assets1,686,296
Long-term Assets1,686,296
Total Current Assets
Cash And Cash Equivalents 182,695
Net Receivables 857,148
Inventory 646,453
Total Current Assets  (as reported)1,686,296
Total Current Assets  (calculated)1,686,296
+/-0
Long-term Assets
Property Plant Equipment 110,061
Goodwill 1,366,097
Intangible Assets 569,807
Other Assets 32,396
Long-term Assets  (as reported)2,083,994
Long-term Assets  (calculated)2,078,361
+/- 5,633

Liabilities & Shareholders' Equity

Total Current Liabilities1,004,611
Long-term Liabilities1,155,940
Total Stockholder Equity1,608,118
Total Current Liabilities
Accounts payable 509,039
Other Current Liabilities 161,091
Total Current Liabilities  (as reported)1,004,611
Total Current Liabilities  (calculated)670,130
+/- 334,481
Long-term Liabilities
Other Liabilities 169,925
Long-term Liabilities  (as reported)1,155,940
Long-term Liabilities  (calculated)169,925
+/- 986,015
Total Stockholder Equity
Common Stock9,118
Retained Earnings 549,830
Other Stockholders Equity 5,421
Total Stockholder Equity (as reported)1,608,118
Total Stockholder Equity (calculated)564,369
+/- 1,043,749
Other
Capital Stock9,118
Common Stock Shares Outstanding 56,944
Net Invested Capital 1,608,118
Net Tangible Assets -327,786
Net Working Capital 681,685



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-312011-12-31
> Total Assets 
907,829
943,732
1,069,358
1,069,358
1,126,782
1,138,871
1,117,925
1,117,925
1,452,959
1,452,959
1,433,471
1,433,471
1,506,255
1,506,255
1,483,475
1,483,475
1,522,236
1,522,236
1,654,241
1,654,241
1,731,812
1,731,812
1,949,329
1,949,329
2,093,479
2,093,479
2,187,886
2,187,886
0
2,194,483
0
2,710,150
0
2,946,494
0
3,270,558
0
3,770,290
3,770,29003,270,55802,946,49402,710,15002,194,48302,187,8862,187,8862,093,4792,093,4791,949,3291,949,3291,731,8121,731,8121,654,2411,654,2411,522,2361,522,2361,483,4751,483,4751,506,2551,506,2551,433,4711,433,4711,452,9591,452,9591,117,9251,117,9251,138,8711,126,7821,069,3581,069,358943,732907,829
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
525,244
525,244
591,952
591,952
658,918
658,918
755,419
755,419
837,450
837,450
929,053
929,053
916,210
916,210
946,246
946,246
1,004,679
1,004,679
1,170,673
1,170,673
1,323,641
1,323,641
1,686,296
1,686,296
1,686,2961,686,2961,323,6411,323,6411,170,6731,170,6731,004,6791,004,679946,246946,246916,210916,210929,053929,053837,450837,450755,419755,419658,918658,918591,952591,952525,244525,24400000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,502
56,502
54,121
54,121
61,383
61,383
68,215
68,215
85,162
85,162
114,435
114,435
104,357
104,357
0
105,489
0
169,008
0
138,384
0
177,879
0
182,695
182,6950177,8790138,3840169,0080105,4890104,357104,357114,435114,43585,16285,16268,21568,21561,38361,38354,12154,12156,50256,50200000000000000
       Net Receivables 
159,842
164,651
195,528
195,528
241,282
253,352
204,495
204,495
291,860
291,860
241,076
241,076
304,813
304,813
259,417
259,417
325,359
325,359
321,437
321,437
405,972
405,972
387,936
387,936
466,713
466,713
425,443
425,443
457,461
457,461
457,384
457,384
615,829
615,829
602,145
602,145
857,148
857,148
857,148857,148602,145602,145615,829615,829457,384457,384457,461457,461425,443425,443466,713466,713387,936387,936405,972405,972321,437321,437325,359325,359259,417259,417304,813304,813241,076241,076291,860291,860204,495204,495253,352241,282195,528195,528164,651159,842
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,115
5,115
0
0
10,272
10,272
0
0
485
485
0
0
87
87
0
0
1
1
0
0
61
61
0
0
0061610011008787004854850010,27210,272005,1155,11500000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,164,426
0
1,271,676
0
1,248,237
0
1,705,471
0
1,775,821
0
1,946,917
0
2,083,994
2,083,99401,946,91701,775,82101,705,47101,248,23701,271,67601,164,4260000000000000000000000000
       Property Plant Equipment 
5,062
7,507
16,613
16,613
16,984
16,709
17,541
17,541
18,023
18,023
18,254
18,254
20,102
20,102
20,895
20,895
19,373
19,373
18,827
18,827
17,585
17,585
25,262
25,262
78,697
78,697
104,094
104,094
90,914
90,914
107,504
107,504
96,220
96,220
97,932
97,932
110,061
110,061
110,061110,06197,93297,93296,22096,220107,504107,50490,91490,914104,094104,09478,69778,69725,26225,26217,58517,58518,82718,82719,37319,37320,89520,89520,10220,10218,25418,25418,02318,02317,54117,54116,70916,98416,61316,6137,5075,062
       Goodwill 
318,704
336,134
362,756
362,756
0
0
370,018
370,018
0
0
490,776
490,776
0
0
508,133
508,133
0
0
567,547
567,547
0
0
663,628
663,628
666,667
666,667
749,001
749,001
0
743,814
0
1,022,593
0
1,088,574
0
1,257,011
0
1,366,097
1,366,09701,257,01101,088,57401,022,5930743,8140749,001749,001666,667666,667663,628663,62800567,547567,54700508,133508,13300490,776490,77600370,018370,01800362,756362,756336,134318,704
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,596
3,596
3,554
3,554
3,438
3,438
3,603
3,603
3,818
3,818
4,275
4,275
5,433
5,433
0
0
0
0
0
0
0
0
0
0
00000000005,4335,4334,2754,2753,8183,8183,6033,6033,4383,4383,5543,5543,5963,59600000000000000
       Intangible Assets 
606,806
624,037
670,929
670,929
668,398
665,798
665,077
665,077
886,874
886,874
907,219
907,219
898,101
898,101
907,558
907,558
883,419
883,419
948,859
948,859
931,452
931,452
376,001
376,001
375,143
375,143
378,485
392,248
0
372,973
0
544,243
0
551,235
0
551,088
0
569,807
569,8070551,0880551,2350544,2430372,9730392,248378,485375,143375,143376,001376,001931,452931,452948,859948,859883,419883,419907,558907,558898,101898,101907,219907,219886,874886,874665,077665,077665,798668,398670,929670,929624,037606,806
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,164,426
0
1,271,676
0
0
0
0
0
0
0
0
0
0
00000000001,271,67601,164,4260000000000000000000000000
> Total Liabilities 
935,735
993,385
1,136,408
1,136,408
1,190,299
1,204,060
587,120
587,120
815,444
815,444
779,640
779,640
825,458
825,458
761,416
761,416
808,669
808,669
925,060
925,060
992,522
992,522
1,162,981
1,162,981
1,279,882
1,279,882
1,321,361
1,321,361
0
1,347,336
0
1,452,299
0
1,618,118
0
1,809,204
0
2,160,551
2,160,55101,809,20401,618,11801,452,29901,347,33601,321,3611,321,3611,279,8821,279,8821,162,9811,162,981992,522992,522925,060925,060808,669808,669761,416761,416825,458825,458779,640779,640815,444815,444587,120587,1201,204,0601,190,2991,136,4081,136,408993,385935,735
   > Total Current Liabilities 
178,590
303,159
229,233
229,233
283,733
288,396
201,783
201,783
337,956
337,956
283,093
283,093
391,847
391,847
291,718
291,718
349,371
349,371
467,091
467,091
430,531
430,531
567,179
567,179
641,093
641,093
649,882
649,882
678,814
678,814
713,472
713,472
949,077
949,077
984,348
984,348
1,004,611
1,004,611
1,004,6111,004,611984,348984,348949,077949,077713,472713,472678,814678,814649,882649,882641,093641,093567,179567,179430,531430,531467,091467,091349,371349,371291,718291,718391,847391,847283,093283,093337,956337,956201,783201,783288,396283,733229,233229,233303,159178,590
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
455,262
455,262
453,230
453,230
1,088
1,088
397
397
465
465
426
426
0
0
0
0
0
0
0
0
0
0
0
0
0000000000004264264654653973971,0881,088453,230453,230455,262455,26200000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
455,262
455,262
453,230
453,230
1,088
1,088
397
397
465
465
426
426
0
0
0
0
0
80,373
0
81,037
0
0
0
0
000081,037080,373000004264264654653973971,0881,088453,230453,230455,262455,26200000000000000
       Accounts payable 
105,508
104,894
136,563
136,563
175,550
175,331
134,694
134,694
197,001
197,001
147,239
147,239
199,661
199,661
170,619
170,619
214,872
214,872
213,437
213,437
250,822
250,822
263,679
263,679
288,360
288,360
279,796
279,796
279,524
279,524
291,844
291,844
370,433
370,433
403,010
403,010
509,039
509,039
509,039509,039403,010403,010370,433370,433291,844291,844279,524279,524279,796279,796288,360288,360263,679263,679250,822250,822213,437213,437214,872214,872170,619170,619199,661199,661147,239147,239197,001197,001134,694134,694175,331175,550136,563136,563104,894105,508
       Other Current Liabilities 
44,337
44,805
50,621
50,621
52,010
50,247
42,751
42,751
55,612
55,612
50,258
50,258
54,061
54,061
49,690
49,690
54,733
54,733
69,763
69,763
80,831
80,831
11,281
11,281
80,574
80,574
14,511
14,511
91,133
91,133
19,436
19,436
134,102
134,102
18,098
18,098
161,091
161,091
161,091161,09118,09818,098134,102134,10219,43619,43691,13391,13314,51114,51180,57480,57411,28111,28180,83180,83169,76369,76354,73354,73349,69049,69054,06154,06150,25850,25855,61255,61242,75142,75150,24752,01050,62150,62144,80544,337
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
638,789
0
671,479
0
668,522
0
738,827
0
669,041
0
824,856
0
1,155,940
1,155,9400824,8560669,0410738,8270668,5220671,4790638,7890000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
525,833
0
565,646
0
565,274
0
0
0
0
0
0
0
0
00000000565,2740565,6460525,8330000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-455,262
-455,262
-453,230
-453,230
-1,088
-1,088
-397
-397
-465
-465
-426
-426
0
74,828
0
0
0
81,318
0
0
0
70,729
0
0
0070,72900081,31800074,8280-426-426-465-465-397-397-1,088-1,088-453,230-453,230-455,262-455,26200000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
275,244
0
0
00275,24400000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
530,805
530,805
637,515
637,515
653,831
653,831
680,797
680,797
722,059
722,059
713,567
713,567
729,181
729,181
739,290
739,290
786,348
786,348
813,597
813,597
866,525
866,525
0
847,147
0
1,257,851
0
1,328,376
0
1,459,825
0
1,608,118
1,608,11801,459,82501,328,37601,257,8510847,1470866,525866,525813,597813,597786,348786,348739,290739,290729,181729,181713,567713,567722,059722,059680,797680,797653,831653,831637,515637,515530,805530,805000000
   Retained Earnings 
0
0
0
0
0
0
0
0
0
0
18,298
18,298
34,528
34,528
68,160
68,160
82,077
82,077
116,582
116,582
136,511
136,511
181,983
181,983
203,433
196,616
247,321
247,321
263,837
263,837
320,498
320,498
368,107
368,107
463,164
463,164
549,830
549,830
549,830549,830463,164463,164368,107368,107320,498320,498263,837263,837247,321247,321196,616203,433181,983181,983136,511136,511116,582116,58282,07782,07768,16068,16034,52834,52818,29818,2980000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
657,514
0
657,514
0
657,514
0
0
0
0
0
0
0
0
00000000657,5140657,5140657,5140000000000000000000000000
   Treasury Stock00000000-3,8940-4,6860-4,686000-5,683-5,683-7,193-7,193-5,189-5,189-5,189-5,189-3,118-3,118-3,118-3,1180000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue3,435,249
Cost of Revenue-2,598,934
Gross Profit836,315836,315
 
Operating Income (+$)
Gross Profit836,315
Operating Expense-3,125,085
Operating Income310,164-2,288,770
 
Operating Expense (+$)
Research Development-
Selling General Administrative148,977
Selling And Marketing Expenses-
Operating Expense3,125,085148,977
 
Net Interest Income (+$)
Interest Income1,803
Interest Expense-18,536
Net Interest Income-17,884-16,733
 
Pretax Income (+$)
Operating Income310,164
Net Interest Income-17,884
Other Non-Operating Income Expenses-
Income Before Tax (EBT)283,827310,164
EBIT - interestExpense = 289,219
283,827
225,772
Interest Expense18,536
Earnings Before Interest and Taxes (ebit)307,755302,363
Earnings Before Interest and Taxes (ebitda)395,226
 
After tax Income (+$)
Income Before Tax283,827
Tax Provision-76,591
Net Income From Continuing Ops207,236207,236
Net Income207,236
Net Income Applicable To Common Shares207,276
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses66,194
Total Other Income/Expenses Net-17,884
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
0QGU.LSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.LSE.

0QGU.LSE Daily Candlestick Chart
0QHL.LSE
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QHL.LSE.

0QHL.LSE Daily Candlestick Chart
0QGU.IL
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.IL.

0QGU.IL Daily Candlestick Chart
0Q7S.LSE
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0Q7S.LSE.

0Q7S.LSE Daily Candlestick Chart
0O8F.LSE
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0O8F.LSE.

0O8F.LSE Daily Candlestick Chart
0NX0.LSE
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0NX0.LSE.

0NX0.LSE Daily Candlestick Chart
0MPM.LSE
13 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 0MPM.LSE.

0MPM.LSE Daily Candlestick Chart
0MPJ.LSE
14 minutes ago

I found you a Golden Cross on the daily chart of 0MPJ.LSE.

0MPJ.LSE Daily Candlestick Chart
0MLH.IL
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0MLH.IL.

0MLH.IL Daily Candlestick Chart
0J6X.LSE
20 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 0J6X.LSE.

0J6X.LSE Daily Candlestick Chart
0IXZ.LSE
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IXZ.LSE.

0IXZ.LSE Daily Candlestick Chart
0IT3.IL
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IT3.IL.

0IT3.IL Daily Candlestick Chart
0HAH.LSE
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0HAH.LSE.

0HAH.LSE Daily Candlestick Chart
0H3T.LSE
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0H3T.LSE.

0H3T.LSE Daily Candlestick Chart
0EEE.LSE
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0EEE.LSE.

0EEE.LSE Daily Candlestick Chart
0FM1.LSE
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0FM1.LSE.

0FM1.LSE Daily Candlestick Chart
0DJI.LSE
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0DJI.LSE.

0DJI.LSE Daily Candlestick Chart
JSCP.NYSE ARC
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JSCP.NYSE ARC.

JSCP.NYSE ARC Daily Candlestick Chart
JPMB.NYSE ARC
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPMB.NYSE ARC.

JPMB.NYSE ARC Daily Candlestick Chart
JPIN.NYSE ARC
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPIN.NYSE ARC.

JPIN.NYSE ARC Daily Candlestick Chart
JIGB.NYSE ARC
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JIGB.NYSE ARC.

JIGB.NYSE ARC Daily Candlestick Chart
JHMD.NYSE ARC
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JHMD.NYSE ARC.

JHMD.NYSE ARC Daily Candlestick Chart
IXUS.NASDAQ
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IXUS.NASDAQ.

IXUS.NASDAQ Daily Candlestick Chart
ISWN.NYSE ARC
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISWN.NYSE ARC.

ISWN.NYSE ARC Daily Candlestick Chart
IUSB.NASDAQ
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IUSB.NASDAQ.

IUSB.NASDAQ Daily Candlestick Chart